NASDAQ Composite ended the session with TherapeuticsMD jumping 5.13% to $1.23 on Thursday, after two sequential sessions in a row of losses. NASDAQ Composite dropped 0.94% to $13,818.41, following last session’s upward trend on what was a somewhat rough trend exchanging session today.
TherapeuticsMD today’s close was $1.23, 123.58% below its 52-week high of $2.75.
The company’s growth estimates for the current quarter and the next is 47.6% and 47.4%, respectively.
Year-on-year quarterly revenue growth grew by 42%, now sitting on 64.87M for the twelve trailing months.
TherapeuticsMD’s Stock Yearly Top and Bottom Value
TherapeuticsMD’s stock is valued at $1.23 at 17:46 EST, way below its 52-week high of $2.75 and way higher than its 52-week low of $0.85.
TherapeuticsMD’s Moving Average
TherapeuticsMD’s worth is way below its 50-day moving average of $1.51 and way under its 200-day moving average of $1.46.
More news about TherapeuticsMD.